Vectus Biosystems (ASX:VBS) OCF Yield %: -10.80 (As of Jun. 28, 2026)


ASX:VBS Vectus Biosystems Ltd ASX:VBS
18 GF Score
Price A$0.13
! 2 Warning Signs
View Full Analysis

What is Vectus Biosystems OCF Yield %?

Vectus Biosystems ASX:VBS 18 OCF Yield % is -10.80 as of Jun. 28, 2026. GuruFocus rates ASX:VBS with a GF Score™ of 18/100. The stock has 2 warning signs investors should review. Among 1,417 Biotechnology companies, Vectus Biosystems ranks worse than 55.05% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Vectus Biosystems's Trailing 12-Month Cash Flow from Operations is A$-0.83 Mil, and Market Cap is A$7.69 Mil. Therefore, Vectus Biosystems's OCF Yield % for today is -10.80%.

The historical rank and industry rank for Vectus Biosystems's OCF Yield % or its related term are showing as below:

ASX:VBS' s OCF Yield % Range Over the Past 10 Years
Min: -10.8   Med: 0   Max: -10.8
Current: -10.8


During the past 10 years, the highest OCF Yield % of Vectus Biosystems was -10.80%. The lowest was -10.80%. And the median was %.

ASX:VBS's OCF Yield % is ranked worse than
55.05% of 1417 companies
in the Biotechnology industry
Industry Median: -8.4 vs ASX:VBS: -10.80

Vectus Biosystems's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Vectus Biosystems OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Vectus Biosystems OCF Yield % Related Terms


Vectus Biosystems OCF Yield % Historical Data

* Premium members only.

The historical data trend for Vectus Biosystems's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vectus Biosystems OCF Yield % Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.62 -12.49 -10.05 -49.62 -38.95

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.61 -61.75 -8.29 -61.94 -3.55

ASX:VBS vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Vectus Biosystems's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's OCF Yield % falls into.


ASX:VBS
18GF Score
Vectus Biosystems Ltd ASX:VBS
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vectus Biosystems OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Vectus Biosystems's OCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-0.83 / 2.13112
=-38.95%

Vectus Biosystems's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.17 * 2 / 9.59004
=-3.55%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -10.80 mean?
Vectus Biosystems (ASX:VBS) has a OCF Yield % of -10.80 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vectus Biosystems and its competitors. According to the industry distribution chart, Vectus Biosystems ranks #780 out of 1417 companies in the Biotechnology industry, placing it in the top 55%.
Is Vectus Biosystems' OCF Yield % too high?
Vectus Biosystems' current OCF Yield % is -10.80. Based on the distribution chart, Vectus Biosystems ranks #780 out of 1417 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Vectus Biosystems has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Vectus Biosystems' OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vectus Biosystems ranks #780 out of 1417 companies for OCF Yield %. This places Vectus Biosystems in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vectus Biosystems and its competitors. Vectus Biosystems's current OCF Yield % is -10.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vectus Biosystems stock overvalued right now?
Vectus Biosystems (ASX:VBS) has a current OCF Yield % of -10.80. The current OCF Yield % is -10.80. Vectus Biosystems' overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Vectus Biosystems (ASX:VBS), the current OCF Yield % is -10.80 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vectus Biosystems Business Description

Address 26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase.
18GF Score

Get the complete analysis for ASX:VBS

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.13
Price